Vera D, Pichardo R, Hernández J, Vidal R , Lizardi J, Méndez SN

Idioma: Español
Referencias bibliográficas: 22
Paginas: 20-28
Archivo PDF: 506.41 Kb.

RESUMEN

El diagnóstico diferencial de los desórdenes que usualmente son clasificados como enfermedades hepáticas autoinmunes son hepatitis autoinmune (HAI), cirrosis biliar primaria (CBP) y colangitis esclerosante primaria (CEP), se requiere de la exclusión cuidadosa de otras causas de enfermedad hepática crónica junto con los hallazgos de patrones sugestivos de anormalidades bioquímicas y la presencia de autoanticuerpos convencionales. Se presenta un caso de una mujer con hipertiroidismo autoinmune y cuadro de colangiopatía autoinmune.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mcfarlane I. Autoimmune liver diseases. Scand J Clin Lab Invest 2001; 61: 53-60.

2. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.

3. Lee Y-M, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-33.

4. Nakanuma Y, Yasoshima M, Tsuneyama K, Harada K. Histopathology of primary biliary cirrhosis with emphasis on expression of adhesion molecules. Semin Liver Dis 1997; 17: 35-47.

5. Batts KP, Ludwing J. Histopathology of autoimmune hepatitis, primary biliary cirrhosis and sclerosing cholangitis. In: Krawitt EL, Wiesner RH, Nishioka M. Autoimmune Liver Diseases, 2nd ed. Elsevier, Amsterdam 1998: 115-140.

6. Mieli Vergani G Vergani D. Immunological liver diseases in children. Semin Liver Dis 1998; 18: 271-79.

7. Heathcote EJ. Management of primary biliary cirrhosis. Hepatology 2000; 31: 1005-1013.

8. Wiesner RH. Diagnostic criteria, clinical manifestations and natural history of primary sclerosing cholangitis. In: Krawitt EL, Wiesner RH, Nishioka M eds. Autoimmune Liver Diseases, 2nd ed. Elsevier, Amsterdam; 1998:381-412.

9. Szostecki, Guldner HH, Will H. Autoantibodies against “nuclear dots” in primary biliary cirrhosis. Semin Liver Dis 1997; 17: 71-78.

10. Courvalin J-C, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis 1997: 79-90.

11. Leung PSC, Coppel RL, Ansari A, Muñoz S, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrosis. Semin Liver Dis 1997; 17: 61-69.

12. Neuberger J, Thompson R. PBC and AMA What is the connection? Hepatology 1999; 29: 271-276.

13. Jayant A Talwalkar, Keith D. Lindor. Primary biliary cirrhosis. Lancet 2003; 362: 53-61.

14. Angulo P, Lindor KD. Chapter 76. Primary Biliary Cirrhosis. Feldman: Sleisenger & Fordmtran’s Gastrointestinal and Liver Disease, 7th ed. 2002.

15. Pyrsopoulos NT, Primary Biliary Cirrhosis. Last Update: July 30, 2002.

16. Marshall MK. Primary Biliary Cirrhosis. N Engl J Med 1996; 335: 1570-79.

17. Nieri S, Ricardo CG, Salvadori G, Surrenti S. Primary biliary cirrosis and Graves’ disease. J Clin Gastroenterol 1985; 7: 434-37.

18. Zein CO, Angulo P, Lindor KD. When is a liver biopsy needed in the diagnosis of primary biliary cirrhosis? Clin Gastroenterol Hepatol 2003; 1: 89-96.

19. Youssef WI, Mullen KD. The liver in other (nondiabetic) endocrine disorders. Clinics in Liver Disease 2002; 6(4).

20. Malik R, Hodgson H. The relationship between the thyroid gland and liver. Q Med 2002; 95: 559-569.

21. Serena LNP, Crawford PJ. W. Burnham WR, Burroughs. Reversible Jaundice in Primary cirrhosis Due to Hyperthyroidism. Gastroenterology 1994; 106: 1342-43.

22. Floreani A, Caroli, Chiramonte M, Gasparoni P, Naccarato R. Hyperthyroidism associated with primary biliary cirrhosis. Rec Prog Med 1989; 80: 582-583.